IP Library Granted Patent US 8,642,255
Granted Patent B2
US 8,642,255 · App. 12/934,644 · Granted Feb 4, 2014

Materials and methods for hypothermic collection of whole blood

Inventors: Ian B. Nicoud (Seattle, WA); Dominic M. Clarke (Bothell, WA); Aby J. Mathew (Vestal, NY); Michael Rice (Woodinville, WA)
Assignee: Biolife Solutions, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,255
App. No.
12/934,644
Granted
Feb 4, 2014
Kind
B2
Abstract

The present invention relates to materials and methods for hypothermic collection of whole blood, and components thereof, which can extend the holding time of blood beyond the current useable limit. Additionally, blood can be drawn directly into a hypothermic preservation solution without the addition of standard anticoagulants. This is enabled by providing sustained cellular viability under hypothermic conditions using a nutrient matrix devoid of animal proteins and containing energy substrates, free-radical scavengers, and impermeants that is ionically balanced for storage of biologic materials at low temperatures to prevent cellular stress-induced apoptosis.

Claims (17)

1. A method of harvesting whole blood, the method comprising:

a) providing a volume of whole blood from a donor; and,

b) mixing, in a container, the volume of whole blood, or a portion thereof, with a volume of preservation solution adapted for cellular osmotic balance at hypothermic temperatures, such that the ratio of whole blood to preservation solution is at least about 1:0.1 by volume,

c) maintaining the mixture of whole blood and preservation solution at hypothermic temperatures,

wherein the volume of whole blood, the volume of preservation solution, and the container are free from an exogenously-introduced anticoagulant reagent, and

wherein the preservation solution comprises an ingredient selected from the group consisting of: an aqueous solution of electrolytes containing potassium ions at a concentration range of from about 35 to about 45 mM, sodium ions at a concentration range of from about 80 to about 120 mM, magnesium ions at a concentration range of from about 2 to about 10 mM, chloride ions at a concentration range of from about 15 to about 20 mM, and calcium ions at a concentration range of from about 0.01 to about 0.1 mM; an impermeant anion; mannitol; a macromolecular oncotic agent; at least one simple sugar; a substrate for the regeneration of ATP; a biological pH buffer effective under physiological hypothermic conditions; and combinations thereof.

2. The method of claim 1 , wherein the ratio of whole blood to preservation solution is at least about 1:0.5, 1:1, 1:2, 1:5, or 1:10.

3. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C.

4. The method of claim 1 wherein the preservation solution comprises an aqueous solution of electrolytes containing potassium ions at a concentration range of from about 35 to about 45 mM, sodium ions at a concentration range of from about 80 to about 120 mM, magnesium ions at a concentration range of from about 2 to about 10 mM, chloride ions at a concentration range of from about 15 to about 20 mM, and calcium ions at a concentration range of from about 0.01 to about 0.1 mM; an impermeant anion; mannitol; a macromolecular oncotic agent; at least one simple sugar; a substrate for the regeneration of ATP; and a biological pH buffer effective under physiological hypothermic conditions.

5. The method of claim 4 wherein the preservation solution further comprises glutathione, a vitamin E derivative, an antioxidant, and combinations thereof.

6. The method of claim 1 wherein the whole blood is cord blood.

7. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 24 hours.

8. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 48 hours.

9. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 72 hours.

10. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 7 days.

11. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 14 days.

12. The method of claim 1 , wherein the mixture of whole blood and preservation solution is maintained at about 2° C. to about 18° C. for at least 21 days.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Mar 26, 2014
From: TAURUS4757 GMBH (SUCCESSOR IN INTEREST TO THOMAS GIRSCHWEILER); WAVI HOLDING AG (SUCCESSOR IN INTEREST TO WALTER VILLIGER)
To: BIOLIFE SOLUTIONS, INC.
Reel/Frame 032525/0369 →
SECURITY AGREEMENT Recorded Sep 28, 2011
From: BIOLIFE SOLUTIONS, INC.
To: VILLIGER, WALTER; GIRSCHWEILER, THOMAS
Reel/Frame 026983/0521 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2011
From: NICOUD, IAN B.; CLARKE, DOMINIC M.; MATHEW, ABY J.; RICE, MICHAEL
To: BIOLIFE SOLUTIONS, INC.
Reel/Frame 026007/0293 →
Continuity (3)
Provisional Application 61039966 · Mar 27, 2008
Provisional Application 61039978 · Mar 27, 2008
Related Publication 20110152719A1 · Jun 23, 2011